Clinical Trials in China / NCT06595342
Starting soon
Observational
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
NCT06595342 · tracked via the Priya Life Science China tracker
Condition(s) studied
Cervical Artery StenosisIntracranial Artery Stenosis
Investigational drug(s) / intervention(s)
No intervention
No intervention: no intervention
Study summary
The aim of this study is to establish a prospective cohort of patients with cervical/intracranial arteries stenosis in China.
Eligibility
Inclusion Criteria:
1. Age ≥ 40 and ≤ 80 years;
2. Ultrasound or imaging examinations indicating cervical artery stenosis and/or intracranial artery stenosis (including mild, moderate, severe stenosis, or occlusion);
3. Willing to participate and signing the informed consent form.
Exclusion Criteria:
1. Patients with stroke occurring within the past year;
2. Patients with severe systemic diseases, such as respiratory failure, renal failure, gastrointestinal bleeding, coagulation disorders, malignancies, etc.;
3. Patients with a life expectancy of less than one year or those who are unable to complete the study for other reasons.
Primary outcome measure(s)
- Incidence of stroke — One year
Incidence of stroke events including ischemic stroke, transient ischaemic attack and haemorrhagic stroke.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| First Hospital of Jilin University | Changchun | Jilin |
More The First Hospital of Jilin University trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06595342 on ClinicalTrials.gov ↗ ← All trials in China